Skip to main content

EFFECTS OF ORAL LEVOSIMENDAN (ODM-109) ON RESPIRATORY FUNCTION IN PATIENTS WITH ALS: OPEN-LABEL EXTENSION FOR PATIENTS COMPLETING STUDY 3119002

Clinical Trial Grant
Duke Scholars

Administered By

Neurology

Awarded By

Orion Corporation

Start Date

December 10, 2019

End Date

March 31, 2021
 

Administered By

Neurology

Awarded By

Orion Corporation

Start Date

December 10, 2019

End Date

March 31, 2021